[Trends of therapy in states of so-called hypoxemic-hypercapnic respiratory insufficiency].
D000136:Acid-Base Equilibrium; D000142:Acidosis, Respiratory / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006935:Hypercapnia / Q000188:drug therapy / Q000209:etiology; D000860:Hypoxia / Q000188:drug therapy / Q000209:etiology*; D000451:Mineralocorticoid Receptor Antagonists; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000150:complications* / Q000188:drug therapy
D001639:Bicarbonates; D001993:Bronchodilator Agents; D002257:Carbonic Anhydrase Inhibitors; D000697:Central Nervous System Stimulants; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists
Orientamenti di terapia negli stati di insufficienza respiratoria conclamata ipossiemico-ipercapnica.